Case study of the anemic patient: epoetin alfa--focus on sexual function.
For patients with end-stage renal disease (ESRD) whose anemia is corrected with Epoetin alfa, a higher hematocrit typically results in increased well-being and renewed interest in life, including sexual activity. Paradoxically, this generally positive therapeutic outcome can result in sexual problems for the patient and his or her partner because of changing expectations. Understanding the physical and psychosocial causes of sexual dysfunction in patients with ESRD, as well as strategies for assessment and intervention, prepares nurses to anticipate sexual problems and intervene appropriately.
Zarifian
A
A
D000328:Adult; D004921:Erythropoietin / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy* / Q000523:psychology*; D008297:Male; D020018:Sexual Dysfunctions, Psychological / Q000451:nursing / Q000523:psychology*
D004921:Erythropoietin